Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. LaForce, N. Herje, P. Dorinsky (Raleigh, Morrisville, United States Of America). The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma. Eur Respir J 2013; 42: Suppl. 57, 3556

Member's Comments

No comment yet.

Related content which might interest you: Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018 Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma? Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes Year: 2019 Audit of the impact of introducing exhaled nitric oxide (FENO) monitoring to an adult asthma clinic in a district general hospital Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma? Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019 Year: 2020 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations Source: Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020 Year: 2020 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance? Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Treatment decisions with an exhaled nitric oxide (eNO)-based algorithm vs a symptoms-based algorithm for asthma in pregnancy Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Personalised exhaled nitric oxygen fraction (FENO)-driven asthma management in primary care: a FENO subgroup analysis of the ACCURATE trial Source: ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019 Year: 2020 Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma Source: Eur Respir J 2007; 30: 545-548 Year: 2007 Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020 Practical utility of portable exhaled nitric oxide (eNO) readings to aid in asthma management plans – a district general hospital (DGH) experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009